The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Acamprosate for alcohol dependence
Open accessAbstract
BACKGROUND: Alcohol dependence is among the main leading health risk factors in most developed and developing countries. Therapeutic success of psychosocial programs for relapse prevention is moderate, but could potentially be increased by an adjuvant treatment with the glutamate antagonist acamprosate. OBJECTIVES: To determine the effectiveness and tolerability of acamprosate in comparison to placebo and other pharmacological agents. SEARCH STRATEGY: We searched the Cochrane Drugs and Alcohol Group (CDAG) Specialized Register, PubMed, EMBASE and CINAHL in January 2009 and inquired manufacturers and researchers for unpublished trials. SELECTION CRITERIA: All double-blind randomised controlled trials (RCTs) which compare the effects of acamprosate with placebo or active control on drinking-related outcomes. DATA COLLECTION AND ANALYSIS: Two authors independently extracted data. Trial quality was assessed by one author and cross-checked by a second author. Individual patient data (IPD) meta-analyses were used to verify the primary effectiveness outcomes. MAIN RESULTS: 24 RCTs with 6915 participants fulfilled the criteria of inclusion and were included in the review. Compared to placebo, acamprosate was shown to significantly reduce the risk of any drinking RR 0.86 (95% CI 0.81 to 0.91); NNT 9.09 (95% CI 6.66 to 14.28) and to significantly increase the cumulative abstinence duration MD 10.94 (95% CI 5.08 to 16.81), while secondary outcomes (gamma-glutamyltransferase, heavy drinking) did not reach statistical significance. Diarrhea was the only side effect that was more frequently reported under acamprosate than placebo RD 0.11 (95% 0.09 to 0.13); NNTB 9.09 (95% CI 7.69 to 11.11). Effects of industry-sponsored trials RR 0.88 (95% 0.80 to 0.97) did not significantly differ from those of non-profit funded trials RR 0.88 (95% CI 0.81 to 0.96). In addition, the linear regression test did not indicate a significant risk of publication bias (p = 0.861). AUTHORS' CONCLUSIONS: Acamprosate appears to be an effective and safe treatment strategy for supporting continuous abstinence after detoxification in alcohol dependent patients. Even though the sizes of treatment effects appear to be rather moderate in their magnitude, they should be valued against the background of the relapsing nature of alcoholism and the limited therapeutic options currently available for its treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Acamprosate and its efficacy in treating alcohol dependent adolescents
Niederhofer, H., & Staffen, W. (2003) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-003-0327-1 · Cited by 55
RetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Confirmation Bias: A Ubiquitous Phenomenon in Many Guises
Nickerson, R. S. (1998) · Review of General Psychology · doi:10.1037/1089-2680.2.2.175 · Cited by 7,267
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
The Michigan Alcoholism Screening Test: The Quest for a New Diagnostic Instrument
SELZER, M. L. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.12.1653 · Cited by 3,438
Chapter 9: Analysing Data and Undertaking Meta-Analyses
Deeks, J. J., Higgins, J. P. T., & Altman, D. G. (2008) · Cited by 2,782
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
(1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.7 · Cited by 1,905
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
The ESEMeD/MHEDEA 2000 Investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00327.x · Cited by 1,819
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665
Summing Up: The Science of Reviewing Research
Light, R. J., & Pillemer, D. B. (1984) · Harvard University Press eBooks · doi:10.4159/9780674040243 · Cited by 1,427
Undue reliance on I 2 in assessing heterogeneity may mislead
Rücker, G., Schwarzer, G., Carpenter, J. R., & Schumacher, M. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-79 · Cited by 1,287
Alcohol dependence syndrome: Measurement and validation.
Skinner, H. A., & Allen, B. A. (1982) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.91.3.199 · Cited by 1,061
Moher, D., Jones, A., Lepage, L., & for the CONSORT Group (2001) · JAMA · doi:10.1001/jama.285.15.1992 · Cited by 1,027
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F. S., Dickinson, H. O., Beyer, F. R., Campbell, F., Schlesinger, C., Heather, N., Saunders, J. B., Burnand, B., & Pienaar, E. D. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub3 · Cited by 746
Intention-to-Treat Analysis: Implications for Quantitative and Qualitative Research
NEWELL, D. J. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.5.837 · Cited by 715
Statistical Problems in the Reporting of Clinical Trials
Pocock, S. J., Hughes, M. D., & Lee, R. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170706 · Cited by 662
Rates and predictors of relapse after natural and treated remission from alcohol use disorders
Moos, R. H., & Moos, B. S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01310.x · Cited by 601
A comparison of statistical methods for meta‐analysis
Brockwell, S. E., & Gordon, I. R. (2001) · Statistics in Medicine · doi:10.1002/sim.650 · Cited by 573
Lefebvre, C., Manheimer, E., & Glanville, J. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch6 · Cited by 559
Subverting Randomization in Controlled Trials
Schulz, K. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530180050029 · Cited by 516
Carmen, B., Angeles, M., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504
Relapse Prevention by Acamprosate: Results From a Placebo-Controlled Study on Alcohol Dependence
Sass, H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080023006 · Cited by 479
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials
Pildal, J., Hrobjartsson, A., Jorgensen, K., Hilden, J., Altman, D., & Gotzsche, P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym087 · Cited by 472
Kiefer, F., Jahn, H., Tarnaske, T., Helwig, H., Briken, P., Holzbach, R., Kämpf, P., Stracke, R., Baehr, M., Naber, D., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.92 · Cited by 400
Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality
Huwiler-Müntener, K. (2002) · JAMA · doi:10.1001/jama.287.21.2801 · Cited by 397
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐Analysis
Kranzler, H. R., & Van Kirk, J. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02356.x · Cited by 390
Mann, K., Lehert, P., & Morgan, M. Y. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000108656.81563.05 · Cited by 364
Self-citationSAFTEE: a technique for the systematic assessment of side effects in clinical trials.
Levine, J., & Schooler, N. (1986) · PubMed · Cited by 362
Antidepressants versus placebo for depression in primary care
Arroll, B., Elley, C. R., Fishman, T., Goodyear-Smith, F. A., Kenealy, T., Blashki, G., Kerse, N., & MacGillivray, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007954 · Cited by 352
Alcoholics Anonymous and other 12-step programmes for alcohol dependence
Ferri, M., Amato, L., & Davoli, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005032.pub2 · Cited by 347
Active placebos versus antidepressants for depression
Moncrieff, J., Wessely, S., & Hardy, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003012.pub2 · Cited by 342
Comparison of acamprosate and placebo in long-term treatment of alcohol dependence
Whitworth, A. B., Oberbauer, H., Fleischhacker, W. W., Lesch, O. M., Walter, H., Nimmerrichter, A., Platz, T., Fischer, F., & Potgieter, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91682-7 · Cited by 320
Rösner, S., Leucht, S., Lehert, P., & Soyka, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107078308 · Cited by 300
Self-citationAnti-craving compounds for ethanol: new pharmacological tools to study addictive processes
Spanagel, R., & Zieglgänsberger, W. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)89800-8 · Cited by 291
Brief interventions for heavy alcohol users admitted to general hospital wards
McQueen, J., Howe, T. E., Allan, L., Mains, D., & Hardy, V. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005191.pub3 · Cited by 285
Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat
Spanagel, R., Hölter, S. M., Allingham, K., Landgraf, R., & Zieglgänsberger, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00174-4 · Cited by 274
DOUBLE-BLIND RANDOMIZED MULTICENTRE TRIAL OF ACAMPROSATE IN MAINTAINING ABSTINENCE FROM ALCOHOL
(1995) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045720 · Cited by 273
Meta‐analysis of continuous outcome data from individual patients
Higgins, J. P. T., Whitehead, A., Turner, R. M., Omar, R. Z., & Thompson, S. G. (2001) · Statistics in Medicine · doi:10.1002/sim.918 · Cited by 265
A multilevel model framework for meta-analysis of clinical trials with binary outcomes
Turner, R. M., Omar, R. Z., Yang, M., Goldstein, H., & Thompson, S. G. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001230)19:24<3417::aid-sim614>3.0.co;2-l · Cited by 265
Sobell, L. C., Sobell, M. B., Riley, D. M., Schuller, R., Pavan, D. S., Cancilla, A., Klajner, F., & Leo, G. I. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.225 · Cited by 218
Chick, J. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.2.176 · Cited by 213
MASON, B., GOODMAN, A., CHABAC, S., & LEHERT, P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.02.002 · Cited by 212
Self-citationRiley, R. D., Simmonds, M. C., & Look, M. P. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.09.009 · Cited by 195
Combined Efficacy of Acamprosate and Disulfiram in the Treatment of Alcoholism: A Controlled Study
Besson, J., Aeby, F., Kasas, A., Lehert, P., & Potgieter, A. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04295.x · Cited by 192
Self-citationACAMPROSATE APPEARS TO DECREASE ALCOHOL INTAKE IN WEANED ALCOHOLICS
LHUINTRE, J. P., MOORE, N., TRAN, G., STERU, L., LANGRENON, S., DAOUST, S., PAROT, P., LADURE, P., LIBERT, C., BOISMARE, F., et al. (1990) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045057 · Cited by 189
Outcome selection bias in meta-analysis
Williamson, P. R., Gamble, C., Altman, D. G., & Hutton, J. L. (2005) · Statistical Methods in Medical Research · doi:10.1191/0962280205sm415oa · Cited by 188
Pelc, I., Verbanck, P., Bon, O. L., Gavrilovic, M., Lion, K., & Lehert, P. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.1.73 · Cited by 184
Self-citationAcamprosate in alcohol dependence: how does it work?
LITTLETON, J. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb01088.x · Cited by 178
Heyser, C. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00130-9 · Cited by 176
Zeise, M. L., Kasparov, S., Capogna, M., & Zieglgänsberger, W. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90682-8 · Cited by 175
Chlorpromazine versus placebo for schizophrenia
Adams, C. E., Awad, G. A., Rathbone, J., Thornley, B., & Soares-Weiser, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000284.pub3 · Cited by 171
ABILITY OF CALCIUM BIS ACETYL HOMOTAURINE, A GABA AGONIST, TO PREVENT RELAPSE IN WEANED ALCOHOLICS
Lhuintre, J.-P., Moore, N., Saligaut, C., Boismare, F., Daoust, M., Chretien, P., Tran, G., & Hillemand, B. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91615-0 · Cited by 166
Morley, K. C., Teesson, M., Reid, S. C., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J. R., Richardson, K., & Haber, P. S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01555.x · Cited by 165
Naassila, M., Hammoumi, S., Legrand, E., Durbin, P., & Daoust, M. (1998) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199806000-00005 · Cited by 164
CONGENITAL LYSINE INTOLERANCE WITH PERIODIC AMMONIA INTOXICATION
Colombo, J. P., Richterich, R., Spahr, A., Donath, A., & Rossi, E. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91924-5 · Cited by 162
Compelling or irrelevant? Using number needed to treat can help decide
Citrome, L. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01194.x · Cited by 158
Acamprosate: Recent Findings and Future Research Directions
Mann, K. F., Kiefer, F., Spanagel, R., & Littleton, J. M. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00690.x · Cited by 156
Tempesta, E. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.2.202 · Cited by 154
Лааксонен, Э., Koski‐Jännes, A., Salaspuro, M. P., Ahtinen, H., & Alho, H. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm136 · Cited by 150
On the Loss‐of‐Control Phenomenon in Alcoholism
Keller, M. (1972) · British Journal of Addiction to Alcohol & Other Drugs · doi:10.1111/j.1360-0443.1972.tb01188.x · Cited by 143
Bachteler, D., Economidou, D., Danysz, W., Ciccocioppo, R., & Spanagel, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300657 · Cited by 136
Acamprosate treatment in a long-term community-based alcohol rehabilitation programme
Poldrugo, F. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02873.x · Cited by 133
Littleton, J. M., & Zieglgänsberger, W. (2003) · American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00492.x · Cited by 121
NALTREXONE VERSUS ACAMPROSATE: ONE YEAR FOLLOW-UP OF ALCOHOL DEPENDENCE TREATMENT
Rubio, G. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.5.419 · Cited by 116
Gual, A., & Lehert, P. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.5.413 · Cited by 112
Self-citationA Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone
Mason, B. J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00368-8 · Cited by 110
An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence
DE SOUSA, A., & DE SOUSA, A. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh187 · Cited by 107
Acamprosate and Prevention of Relapse in Alcoholics
Geerlings, P. J., Ansoms, C., & van den Brink, W. (2009) · European Addiction Research · doi:10.1159/000259166 · Cited by 99
Verheul, R., Lehert, P., Geerlings, P. J., Koeter, M. W. J., & van den Brink, W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1991-7 · Cited by 94
Self-citationTannock, I. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.206 · Cited by 90
Effects of Acamprosate on Ethanol-Seeking and Self-Administration in the Rat
Czachowski, C. L., Legg, B. H., & Samson, H. H. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200103000-00005 · Cited by 89
Olive, M. F., Nannini, M., Ou, C. J., Koenig, H. N., & Hodge, C. W. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01272-4 · Cited by 88
Namkoong, K. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg038 · Cited by 84
McGeehan, A., & Olive, M. F. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705059 · Cited by 82
Brief interventions for heavy alcohol users admitted to general hospital wards
McQueen, J., Howe, T. E., Allan, L., & Mains, D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005191.pub2 · Cited by 79
Johnson, B. A., O’Malley, S. S., Ciraulo, D. A., Roache, J. D., Chambers, R. A., Sarid‐Segal, O., & Couper, D. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084029.22282.bb · Cited by 76
Pelc, I., Ansoms, C., Lehert, P., Fischer, F., Fuchs, W., Landron, F., Preto, A. J. P., & Morgan, M. Y. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200210000-00010 · Cited by 76
Self-citationUsing Topiramate or Naltrexone for the Treatment of Alcohol‐Dependent Patients
Flórez, G., García‐Portilla, M. P., Álvarez, S., Sáiz, P. A., Nogueiras, L., & Bobes, J. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00680.x · Cited by 71
Staner, L., Boeijinga, P. H., Danel, T., Isabelle, G., Muzet, M., Landron, F., & Luthringer, R. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00180.x · Cited by 68
General Versus Systematic Inquiry about Emergent Clinical Events with SAFTEE
Rabkin, J. G., Markowitz, J. S., OCEPEK-WELIKSON, K., & Wager, S. (1992) · Current Opinion in Cardiology · doi:10.1097/00001573-199202000-00002 · Cited by 67
Pelc, I., Ansoms, C., Lehert, P., Fischer, F., Fuchs, W.-J., Landron, F., Preto, A. J. P., & Morgan, M. Y. (2002) · PubMed · doi:10.1097/01.alc.0000029584.62149.22 · Cited by 66
Self-citationCole, J. C., Littleton, J. M., & Little, H. J. (2000) · Psychopharmacology · doi:10.1007/s002130050009 · Cited by 65
Ooteman, W., Koeter, M. W. J., Verheul, R., Schippers, G. M., & van den Brink, W. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.012 · Cited by 65
DOES PSYCHOSOCIAL TREATMENT ENHANCE THE EFFICACY OF ACAMPROSATE IN PATIENTS WITH ALCOHOL PROBLEMS?
de Wildt, W. A. J. M. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.4.375 · Cited by 64
Direct and Indirect Costs Attributable to Alcohol Consumption in Germany
Konnopka, A., & nig, H.-H. K. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725070-00006 · Cited by 63
Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?
Chick, J., Lehert, P., & Landron, F. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174017 · Cited by 61
Self-citationGeneral Versus Systematic Inquiry about Emergent Clinical Events with SAFTEE
Rabkin, J. G., Markowitz, J. S., OCEPEK-WELIKSON, K., & Wager, S. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199202000-00002 · Cited by 60
Gerra, G., Caccavari, R., Delsignore, R., Bocchi, R., Affini, G. F., & Passeri, M. (1992) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80480-1 · Cited by 57
Sobell, L. C., Toneatto, T., Sobell, M. B., Leo, G. I., & Johnson, L. M. (1992) · Addictive Behaviors · doi:10.1016/0306-4603(92)90011-j · Cited by 51
Pharmacology of Acamprosate: An Overview
Zornoza, T., Cano, M. J., Polache, A., & Granero, L. M. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00260.x · Cited by 51
Pelc, I., Bon, O. L., Verbanck, P., Lehert, P., & Opsomer, L. (1992) · Springer eBooks · doi:10.1007/978-1-4612-2878-3_44 · Cited by 50
Self-citationA PRAGMATIC TRIAL OF ACAMPROSATE IN THE TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE
Kiritze-Topor, P., Huas, D., ROSENZWEIG, C., Comte, S., Paillé, F., & Lehert, P. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh088 · Cited by 50
Self-citation[Acamprosate--a stabilizing factor in long-term withdrawal of alcoholic patients].
Ladewig, D., Knecht, T., Leher, P., & Fendl, A. (1993) · PubMed · Cited by 50
[Does acamprosate diminish the appetite for alcohol in weaned alcoholics?].
Roussaux, J. P., Hers, D., & Ferauge, M. (1996) · PubMed · Cited by 49
Lack of effects of Ca-acetyl homotaurinate on chronic and acute toxicities of ethanol in rats
Magnen, J. L., Tran, G., & Durlach, J. (1987) · Alcohol · doi:10.1016/0741-8329(87)90006-1 · Cited by 43
Baltieri, D. A., & de Andrade, A. G. (2004) · Journal of Studies on Alcohol · doi:10.15288/jsa.2004.65.136 · Cited by 41
Soyka, M., Preuss, U. W., & Schütz, C. G. (2002) · Drugs in R&D · doi:10.2165/00126839-200203010-00001 · Cited by 40
Self-citationBoeijinga, P. H., Parot, P., Soufflet, L., Landron, F., Danel, T., Gendre, I., Muzet, M., Demazières, A., & Luthringer, R. (2004) · Neuropsychobiology · doi:10.1159/000077944 · Cited by 40
Feeney, G. F. X., Young, R. M., Connor, J. P., Tucker, J., & McPherson, A. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01019.x · Cited by 40
Kampman, K. M., Pettinati, H. M., Lynch, K. G., Xie, H., Dackis, C. A., Oslin, D. W., Sparkman, T., Sharkoski, T., & O’Brien, C. P. (2009) · Addictive Behaviors · doi:10.1016/j.addbeh.2009.03.014 · Cited by 38
Reid, S., Teesson, M., Sannibale, C., Matsuda, M., & Haber, P. (2005) · Journal of Studies on Alcohol · doi:10.15288/jsa.2005.66.833 · Cited by 36
Review and discussion of statistical analysis of controlled clinical trials in alcoholism.
Lehert, P. (1993) · PubMed · Cited by 34
Self-citationA Pilot Study of Oxcarbazepine Versus Acamprosate in Alcohol‐Dependent Patients
Croissant, B., Diehl, A., Klein, O., Zambrano, S., Nakovics, H., Heinz, A., & Mann, K. F. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00082.x · Cited by 32
Cano-Cebrián, M. J., Zornoza, T., Guerri, C., Polache, A., & Granero, L. M. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0795-3 · Cited by 27
Hammarberg, A. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh056 · Cited by 21
Treatment of Alcohol and Drug Abuse. An Evidence-Based Review
Berglund, M. (2003) · Lund University Publications (Lund University) · Cited by 18
Long-term effects of pharmacotherapy on relapse prevention in alcohol dependence
Kiefer, F., Andersohn, F., Otte, C., Wolf, K., Jahn, H., & Wiedemann, K. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2004.00093.x · Cited by 17
The effect of acamprosate on alcohol and food craving in patients with alcohol dependence
Han, D. H., Lyool, I. K., Sung, Y. H., Lee, S. H., & Renshaw, P. F. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.014 · Cited by 16
Buri, C., Moggi, F., Giovanoli, A., & Strik, W. K. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm038 · Cited by 15
Meta-Analysis of Pharmacotherapeutic Trials
Schoechlin, C., & Engel, R. R. (2000) · Handbooks of pharmacology and toxicology · doi:10.1201/9781420036961.ch31 · Cited by 9
Research works printed but not linked: 14
- Barrias, 1997, Acamprosate: multicenter Portuguese efficacy and tolerance evaluation study, Psiquiatria Clinica, 18, 149
- Fuchs, 2002, Acamprosate and psychosocial intervention. An integrative treatment approach for prevention of alcohol dependent patients in Switzerland, Praxis (Bern 1994), 91, 735, 10.1024/0369-8394.91.17.735 · doi:10.1024/0369-8394.91.17.735
- Nespor, 2006, Treatment and prevention of alcohol-related problems and evidence based medicine, Casopis Lekaru Ceskych, 145, 964
- Rychlik, 2001, Adjuvant drug treatment of alcoholism with acamprosate: between sectorial budgets and disease management, Deutsche Medizinische Wochenschrift, 126, 899, 10.1055/s-2001-16502 · doi:10.1055/s-2001-16502
- Hopkins, 2002, Naltrexone and acamprosate: Meta-analysis of two medical treatments for alcoholism, Alcoholism: Clinical and Experimental Research, 26, 130A
- International Conference on Harmonisation Guideline for Good ClinicalPractice E6(R1). (http://www.ich.org/LOB/media/MEDIA482.pdf) 1996
- Kadden, 1992, Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide fro Therapists Treating Individuals with Alcohol Abuse and Dependence, 3
- Marlatt, 1985, Relapse prevention
- Miller, 1994, Motivational Enhancement Therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence
- Nowinski, 1995, Twelve Step Facilitation Therapy manual. A clinical research guide for therapists treating individuals with alcohol abuse and dependence
- Pettinati, 2004, Medical Management Treatment Manual. A Clinical Research Guide for MedicallyTrained Clinicians Providing Pharmacotherapy as Part of the Treatment for AlcoholDependence, 2
- Skinner, 1984, Alcohol Dependence Scale: Users Guide
- Spanagel, 2003, Acamprosate--new preclinical research aspects, MMW, Fortschritte der Medizin, 145 Supplement, 61
- The Nordic Cochrane Centre Review Manager (RevMan). 5.0 2008
Cited by
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
Thursz, M., Gual, A., Lackner, C., Mathurin, P., Moreno, C., Spahr, L., Sterneck, M., & Cortez-Pinto, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.018 · Cited by 943
EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.004 · Cited by 720
Schünemann, H. J., Wiercioch, W., Brozek, J., Etxeandia-Ikobaltzeta, I., Mustafa, R. A., Manja, V., Brignardello-Petersen, R., Neumann, I., Falavigna, M., Alhazzani, W., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.09.009 · Cited by 645
Advances in the science and treatment of alcohol use disorder
Witkiewitz, K., Litten, R. Z., & Leggio, L. (2019) · Science Advances · doi:10.1126/sciadv.aax4043 · Cited by 592
Metadata
- Authors
- Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-09-07
- Volume
- 2011
- Issue
- 2
- Pages
- 70-2
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1966583118
- Cited by
- 412
- References
- 124
- FWCI
- 18.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.